Seattle, WANCT07731880Now EnrollingIRB Ready

Malignant Female Reproductive System Neoplasm Clinical Trial in Seattle, WA

Access cutting-edge malignant female reproductive system neoplasm treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.

Sponsored by Fred Hutchinson Cancer Center

Quick Self-Assessment

See if you qualify for this Seattle location

Preparing your pre-screening questions…

Expert Care in Seattle

Access malignant female reproductive system neoplasm specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related malignant female reproductive system neoplasm treatment provided free

Apply for This Seattle Location

Check if you qualify for this malignant female reproductive system neoplasm clinical trial in Seattle, WA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Seattle

    Convenient for WA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Seattle site if eligible
  4. 4Begin participation

About This Malignant Female Reproductive System Neoplasm Study in Seattle

This study is being done to determine how easy it is to use standard of care (SOC) surgical resections or biopsy for SmartMatch analysis to determine treatment options in advanced gynecological malignancies.

Sponsor: Fred Hutchinson Cancer Center

Who Can Participate

Inclusion Criteria

Age ≥ 18 years
Histologically confirmed rare gynecologic malignancy, including but not limited to those listed
Metastatic or unresectable disease, OR disease for which additional systemic therapy is indicated
Fresh tumor tissue available from a SOC surgical procedure or biopsy that in the judgment of the treating team will yield adequate viable tumor for SmartMatch analysis
Eastern Cooperative Oncology Group (ECOG) performance status 0-2
Adequate organ function to receive systemic therapy as determined by the treating oncologist (protocol does not specify thresholds because therapy is not mandated)
Ability to understand and willingness to sign informed consent
Willingness to allow data abstraction from the electronic health record for study endpoints

Exclusion Criteria

Lack of tumor tissue suitable for SmartMatch analysis
Purely borderline tumors or benign ovarian/uterine neoplasms
Any condition that, in the opinion of the treating oncologist or PI, would interfere with receiving systemic therapy
Inability to provide informed consent or comply with study procedures

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Seattle?

Yes, this clinical trial (NCT07731880) has an active research site in Seattle, WA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Malignant Female Reproductive System Neoplasm Treatment Options in Seattle, WA

If you're searching for malignant female reproductive system neoplasm treatment options in Seattle, WA, this clinical trial (NCT07731880) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced malignant female reproductive system neoplasm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all malignant female reproductive system neoplasm clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Seattle, WA

See all ulcerative colitis clinical trials recruiting in Seattle — not just this study.

Browse Ulcerative Colitis Trials in Seattle →

Browse More Trials by Condition

Ulcerative Colitis TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Seattle?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Seattle, WA